Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

Annals of neurology - 1 May 2005

Grossman Murray, Farmer Jennifer, Leight Susan, Work Melissa, Moore Peachie, Van Deerlin Vivianna, Pratico Domenico, Clark Christopher M, Coslett H Branch, Chatterjee Anjan, Gee James, Trojanowski John Q, Lee Virginia M-Y

Abstract excerpt

We assessed cerebrospinal fluid (CSF) levels of tau and other biomarkers of neurodegenerative disease. CSF tau levels vary widely in reports of frontotemporal dementia (FTD). CSF samples were assayed for tau, amyloid beta1-42 (A1-42), and the isoprostane 8,12-iso-iPF2a-VI (iP) prospectively in 64 patients with FTD, retrospectively in 26 autopsied cases with FTD or Alzheimer's disease (AD), and in 13 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Atrophy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cerebral Cortex

Share to Dementia

Share to Frontal Lobe

Share to Neuropsychological Tests

Share to ROC Curve

Share to tau Proteins

Source

Identifiers

PMID: 15852395
DOI: 10.1002/ana.20477

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.PMID 15852395Read ↗

Fluid biomarkers in frontotemporal dementia: past, present and futureSemantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.Semantic proximity Read ↗

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.Semantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Semantic proximity Read ↗

Positron emission tomography in vivo characterisation of the pathology of frontotemporal dementiaSemantic proximity Read ↗

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.Semantic proximity Read ↗

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.Semantic proximity Read ↗

The Use of Proteomics in Biomarker Discovery in Neurodegenerative DiseasesSemantic proximity Read ↗

Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal DementiaSemantic proximity Read ↗

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal DementiasSemantic proximity Read ↗

An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.